Press "esc" to clear
Go to Advanced Search

Showing results

110 of 1081
  • Embargo expired:
    18-Jan-2019 3:00 PM EST

Article ID: 706457

No substantial benefit from transplantation reported for a high-risk leukemia subtype

St. Jude Children's Research Hospital

Study led by St. Jude Children’s Research Hospital found treatment guided by measuring minimal residual disease was associated with better outcomes for hypodiploid acute lymphoblastic leukemia patients

14-Jan-2019 4:05 PM EST
Embargo will expire:
21-Jan-2019 11:00 AM EST
Released to reporters:
17-Jan-2019 3:05 PM EST


A reporter's PressPass is required to access this story until the embargo expires on 21-Jan-2019 11:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


Article ID: 706597

Research reveals mechanism for leukaemia cell growth, prompting new treatment hopes

University of Sussex

A mechanism which drives leukaemia cell growth has been discovered by researchers at the University of Sussex, who believe their findings could help to inform new strategies when it comes to treating the cancer.

16-Jan-2019 1:30 PM EST
  • Embargo expired:
    16-Jan-2019 12:05 AM EST

Article ID: 706443

Study Finds Following Heart Health Guidelines Also Reduces Diabetes Risk

Ohio State University Wexner Medical Center

Lifestyle and health factors that are good for your heart can also prevent diabetes, according to a new study by researchers at The Ohio State University College of Medicine.

14-Jan-2019 2:30 PM EST
  • Embargo expired:
    14-Jan-2019 3:00 PM EST

Article ID: 706324

Study: “Post-normal” science requires unorthodox communication strategies

University of Wisconsin-Madison

“Our aim,” the authors write, “is therefore to use our collective experiences and knowledge to highlight how the current debate about gene drives could benefit from lessons learned from other contexts and sound communication approaches involving multiple actors.”

10-Jan-2019 4:05 PM EST

Article ID: 706405

More accurate leukemia diagnosis expected as researchers refine leukemia classification

St. Jude Children's Research Hospital

More than 90 percent of B-ALL cases can now be classified by subtype, up from 70 percent several years ago. The number of proposed B-ALL subtypes is now 23.

14-Jan-2019 10:05 AM EST

Article ID: 706333

New Leukemia Drug is More Effective and Easier to Use

Loyola University Health System

A landmark study has found that a newer targeted drug is significantly more effective than standard therapy for treating elderly patients with chronic lymphocytic leukemia (CLL). The drug, ibrutinib, attacks cancer cells without damaging normal cells, thus causing fewer side effects.

10-Jan-2019 7:05 PM EST
  • Embargo expired:
    10-Jan-2019 11:00 AM EST

Article ID: 706239

The Pressure’s Off

Harvard Medical School

• Scientists reveal activated structure of a receptor critical for blood pressure, salt homeostasis • Receptor is a target for drugs widely used to treat hypertension

9-Jan-2019 3:30 PM EST

Article ID: 706219

Sex Differences in ‘Body Clock’ May Benefit Women’s Heart Health

American Physiological Society (APS)

Research suggests that a gene that governs the body’s biological (circadian) clock acts differently in males versus females and may protect females from heart disease. The study is the first to analyze circadian blood pressure rhythms in female mice. The research, published ahead of print in the American Journal of Physiology—Regulatory, Integrative and Comparative Physiology, was chosen as an APSselect article for January.

10-Jan-2019 7:00 AM EST

Showing results

110 of 1081

Chat now!